Following positive 1-year outcomes from two phase 3 trials of aflibercept as a treatment for diabetic macular edema, Regeneron Pharmaceuticals announced it plans to submit an application for U.S. marketing approval this year, approximately 1 year ahead…
Neurotech Pharmaceuticals has tapped James Mazzo, former CEO of Abbott Medical Optics, as executive chairman to help advance the biotechnology company’s therapies for chronic retinal disease toward market availability, according to a company news release.Last month, Mazzo was also named as operating partner for Versant Ventures, as well as chairman and CEO of AcuFocus, a company within the Versant portfolio.
Akorn reported generally accepted accounting principles net income of $12.6 million for the quarter ended June 30, up 30.2% from the $9.7 million in net income for the same period last year, according to a company news release. The company set a record…
Encountering a posterior capsule rupture (PCR) and handling it effectively is quiet a challenging task for the surgeon, especially when the PCR occurs in the initial stages of cataract surgery where the nucleus is yet to be emulsified.Mounting the IOL …
Researchers have discovered atomic-scale views of an eye protein that maintains transparency of the lens in the human eye, which could potentially lead to new ways of treating and preventing cataracts…
Patients who are otherwise completely unable to communicate can answer yes or no questions within seconds with the help of a simple system – consisting of just a laptop and camera – that measures nothing but the size of their pupils…